This Is MS Multiple Sclerosis Community: Knowledge & Support

Stanford faculty still taking drug firms' money

This article was in the San Francisco Chronicle today. Interesting read.

http://www.sfgate.com/cgi-bin/article.c ... .DTL&tsp=1

I don't have a problem with drug companies paying academic doctors, other healthcare professionals or researchers for work/advice/consultancy, provided that all payments are fully publically declared.
It is not unusual for a speaker to thank a drug company before a seminar in healthcare circles, the audience understands what this means and are usually more challenging.

MarkW

_________________
Mark Walker - Oxfordshire, England. Registered Pharmacist (UK). 10 years of study around MS.
Mark's CCSVI Report 7-Mar-11:
http://www.telegraph.co.uk/health/8359854/MS-experts-in-Britain-have-to-open-their-minds.html